公开(公告)号：US20240131003A1

公开(公告)日：2024-04-25

申请号：US18537596

申请日：2023-12-12

Applicant: Michael Mong ,  Bao Tran

Inventor： Michael Mong ,  Bao Tran

IPC: A61K31/353 ,  A61H31/00 ,  A61K9/00 ,  A61K31/05 ,  A61K31/164 ,  A61K38/47 ,  A61M16/00

CPC classification number: A61K31/353 ,  A61H31/00 ,  A61K9/0078 ,  A61K31/05 ,  A61K31/164 ,  A61K38/47 ,  A61M16/0003 ,  C12Y302/01035

Abstract: Provided herein are methods of treatment, including methods of treating subjects having or at risk of having or having a viral infection, and specifically a SARS-CoV-2 viral infection. The methods provided include the administration of 4-methylumbelliferone (4-MU), palmitoylethanolamide (PEA), reservatrol, fisetin, H2, nebulized hyaluronidase or combinations thereof. Also provided herein are a respiratory assistance device, methods of generating a customized respiratory assistance device, methods of treating a coronavirus infection, and methods of inhibiting a coronavirus infectivity, virulence and/or spread.

公开(公告)号：US11903921B2

公开(公告)日：2024-02-20

申请号：US17222718

申请日：2021-04-05

Applicant: Michael Mong ,  Bao Tran

Inventor： Michael Mong ,  Bao Tran

IPC: A61M16/00 ,  A61K31/353 ,  A61K31/164 ,  A61K31/05 ,  A61K9/00 ,  A61K38/47 ,  A61H3/00

CPC classification number: A61K31/353 ,  A61H3/00 ,  A61K9/0078 ,  A61K31/05 ,  A61K31/164 ,  A61K38/47 ,  A61M16/0003 ,  C12Y302/01035

Abstract: Provided herein are methods of treatment, including methods of treating subjects having or at risk of having or having a viral infection, and specifically a SARS-CoV-2 viral infection. The methods provided include the administration of 4-methylumbelliferone (4-MU), palmitoylethanolamide (PEA), resveratrol, fisetin, H2, nebulized hyaluronidase or combinations thereof. Also provided herein are a respiratory assistance device, methods of generating a customized respiratory assistance device, methods of treating a coronavirus infection, and methods of inhibiting a coronavirus infectivity, virulence and/or spread.

公开(公告)号：US20210338631A1

公开(公告)日：2021-11-04

申请号：US17222718

申请日：2021-04-05

Applicant: Michael Mong ,  Bao Tran

Inventor： Michael Mong ,  Bao Tran

IPC: A61K31/353 ,  A61K31/164 ,  A61K31/05 ,  A61K38/47 ,  A61M16/00 ,  A61K9/00

Abstract: Provided herein are methods of treatment, including methods of treating subjects having or at risk of having or having a viral infection, and specifically a SARS-CoV-2 viral infection. The methods provided include the administration of 4-methylumbelliferone (4-MU), palmitoylethanolamide (PEA), reservatrol, fisetin, H2, nebulized hyaluronidase or combinations thereof. Also provided herein are a respiratory assistance device, methods of generating a customized respiratory assistance device, methods of treating a coronavirus infection, and methods of inhibiting a coronavirus infectivity, virulence and/or spread.